170 related articles for article (PubMed ID: 35402624)
1. A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma.
Lai X; Wu YK; Hong GQ; Li JK; Luo Q; Yuan J; Dai GH; Liu SQ; Feng HG
J Immunol Res; 2022; 2022():9117205. PubMed ID: 35402624
[TBL] [Abstract][Full Text] [Related]
2. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
3. CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
Peng Q; Huang H; Zhu C; Hou Q; Wei S; Xiao Y; Zhang Z; Sun X
Oxid Med Cell Longev; 2022; 2022():8421813. PubMed ID: 36193067
[TBL] [Abstract][Full Text] [Related]
4. The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma.
Li J; Zhang X; Yao L; Hu K
Aging (Albany NY); 2022 May; 14(10):4513-4529. PubMed ID: 35622386
[TBL] [Abstract][Full Text] [Related]
5. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
[TBL] [Abstract][Full Text] [Related]
6. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
[TBL] [Abstract][Full Text] [Related]
7. Loss of ficolin-3 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Chen CC; Yu TH; Wu CC; Hung WC; Lee TL; Tang WH; Tsai IT; Chung FM; Lee YJ; Hsu CC
Int J Med Sci; 2023; 20(8):1091-1096. PubMed ID: 37484802
[No Abstract] [Full Text] [Related]
8. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
9. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
Yang G; Wang G; Xiong Y; Sun J; Li W; Tang T; Li J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33907851
[TBL] [Abstract][Full Text] [Related]
10. Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis.
Zhang X; Zhang X; Li X; Bao H; Li G; Li N; Li H; Dou J
Med Sci Monit; 2021 Mar; 27():e926760. PubMed ID: 33788826
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
Zhuang L; Yang Z; Meng Z
Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
[TBL] [Abstract][Full Text] [Related]
14. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of an Autophagy-Related Gene Signature for Predicting the Prognosis of Hepatocellular Carcinoma.
Zhang J; Zhang M; Huang J; Zhang G; Li C; Wang X; Kong W
Biomed Res Int; 2021; 2021():7771037. PubMed ID: 34746309
[TBL] [Abstract][Full Text] [Related]
16. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
[TBL] [Abstract][Full Text] [Related]
18. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
[TBL] [Abstract][Full Text] [Related]
19. APC
Shi M; Dai WQ; Jia RR; Zhang QH; Wei J; Wang YG; Xiang SH; Liu B; Xu L
Cancer Lett; 2021 Jan; 496():144-155. PubMed ID: 33039559
[TBL] [Abstract][Full Text] [Related]
20. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
[Next] [New Search]